Analysts project that the global obesity therapeutic market could be worth $100 billion by around 2030, and Barclays estimates the burgeoning weight loss drug industry could reach as high as $200 billion within the next decade
Fast weight loss isnt always safe
These sources may market retatrutide alongside FDA-approved compounds like semaglutide and tirzepatide, sometimes implying a level of pharmaceutical oversight that does not actually exist for retatrutide as an investigational compound
The dysesthesia safety signal may prompt additional scrutiny or requests for supplemental neurological data
Mechanism of Action Glucose Homeostasis: Enhances insulin secretion, suppresses glucagon release Gastric Motility: Delays emptying, promotes satiety signals Cardiovascular: Improves endothelial function, reduces inflammation Neuroprotection: Activates survival pathways, reduces neuroinflammation Renal Protection: Reduces albuminuria, preserves kidney function Hepatic: Improves steatosis, reduces liver inflammation Research Advantages Extended Half-Life: Hours vs
